3137 results for «218»
3137 results
Rapid-fire - Complex procedure in TAVI - Part 2
18 Feb 2024 – From PCR Tokyo Valves 2024
In the second part of this rapid-fire session, we continue to focus on complex cases that might arise during TAVI, such as a case of prosthetic aortic valve endocarditis resulting in cardiogenic shock, treatment of severe AR after infective endocarditis, and more!
Rapid-fire - Complications of Mitral TEER - Part 2
18 Feb 2024 – From PCR Tokyo Valves 2024
Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the second part of this session rapid-fire submission cases [in Japanese].
Nightmares in TAVI: sharing solutions together
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to learn more about bailout techniques for TAVI during uncommon complications, such as late coronary obstruction post-TAVI, a migrated self-expandable valve, or a C-tab induced iatrogenic thoracic aortic dissection after Evolut FX implantation.
Imaging for aortic valve disease
18 Feb 2024 – From PCR Tokyo Valves 2024
Learn about imaging of the aortic valve system in order to better deal with aortic valve disease. Through this series of cases, explore topics such as the impact of implantation depth relative to membranous septum on TAVI outcomes, delve into a meta-analysis exploring the outcomes of...
Complex diagnosis
17 Feb 2024 – From PCR Tokyo Valves 2024
Gain valuable insights in how to deal with complex diagnoses in this session of rapid-fire submissions cases [in Japanese].
Rapid-fire - Challenging structural interventions
21 Nov 2023 – From PCR London Valves 2023
Discover complex scenarios in structural interventions in this session: encounter an uncommon complication – ventricular septal defect – arising from transcatheter aortic valve replacement, delve into the decision-making process for a ventricular septal defect post-myocardial infarction in a young patient, navigate through the complexities of embolic...
Rapid-fire - Combined structural interventions
21 Nov 2023 – From PCR London Valves 2023
Consult this session unraveling the nuances of combined structural interventions, and uncover a unique case of Platypnea-Orthodeoxia syndrome following TAVI, navigate through the complexities of combined TAVR and TMVR in rheumatic heart disease, explore the optimal timing for M-TEER after TAVR in mitral regurgitation, and more!
Rapid-fire - Challenging TAVI procedures - Part 5
21 Nov 2023 – From PCR London Valves 2023
Discover challenging TAVI scenarios in this session: experience the challenges posed by a small annulus with anomalous coronary arteries, delve into the Mitroflow Valve-in-Valve TAVR procedure, witness a unique approach to TAVI in a patient with a mechanical mitral valve, and more!
Rapid-fire - Nightmares in the cathlab - Part 3
21 Nov 2023 – From PCR London Valves 2023
Consult this session to uncover challenging scenarios: navigate the complications of balloon-expanding TAVI embolization triggered by a Starr Edwards valve in the mitral position, delve into the nightmare of an embolic stroke post-TAVI in a patient with a porcelain aorta, explore the complexities of TAVR following two...
Challenges in TAVIs, are there guideline recommendations?
20 Nov 2023 – From PCR London Valves 2023
The EAPCI consensus session emphasized the critical role of evaluating and managing coronary artery disease in TAVI candidates, especially in younger and lower-risk patients. Transcatheter heart valve choice influences future coronary access, emphasizing the need for optimized implantation techniques. In cardiogenic shock due to valvular heart...
Navigating the crossroads of care: challenges in shared decision-making for doctors and patients
20 Nov 2023 – From PCR London Valves 2023
Tune in to understand the significance of shared decision-making, explore its importance, identify potential barriers, recognize the pivotal role of patient perspectives and engagement, and discover strategies to facilitate its successful integration on both local and global scales.
Top Innovations
20 Nov 2023 – From PCR London Valves 2023
Discover the future of cardiac care with these 3 top innovations! ARTERY, revolutionizing structural heart treatment, Vesalius Transfemoral DMR Repair, combining chordal and annular support in one-transfemoral device, and Approxima, a right ventricular reshaping device, offering a fresh perspective on tricuspid regurgitation.
!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice
20 Nov 2023 – From PCR London Valves 2023
Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.
Welcome to GulfPCR Valves 2023
05 Dec 2023 – From GulfPCR-GIM 2023
Find out more about this very first edition of GulfPCR Valves by discovering its Course directors, its objectives, its programme, its partners and its interactivity. If you are a heart valve interventionist or an imager, and you have a keen interest in valve disease, and TAVI in...
TAVI for bicuspid aortic stenosis patients - Recorded cases
05 Dec 2023 – From GulfPCR-GIM 2023
Discover two clinical cases of optimising TAVI procedure in bicuspid aortic valve patients, taking into account the current sizing options in such anatomy.
- An 84-year-old woman with a history of LAD PCI in 2020, presented a symptomatic severe aortic stenosis and grade 3 regurgitation with a preserved LV...
TAVI and access: alternating is wise
16 Jan 2024 – From GulfPCR-GIM 2023
Given that 10-20% of patients have restricted or even impossible femoral access, it is important, for both procedural and patient safety, that alternative access is sometimes considered. Learn what options are available, whether surgical or transcatheter, depending on the patient, and how to put these choices into...
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)